24.01.2025 • NewsElkemsilicones

Elkem Initiates Strategic Review of Silicones Division

Elkem, a Norwegian manufacturer of silicon-based advanced materials, has initiated a strategic review of its Silicones division. The review is initiated with a target to streamline Elkem, as well as to enable the allocation of capital to accelerate growth in the Silicon Products and Carbon Solutions divisions.

According to Elkem, the decision to initiate the strategic review follows a thorough assessment of the growth and return prospects, as well as its capital allocation strategy and the market dynamics in the silicones business.

Elkem's Silicones division products, ranging from silicon metal to upstream siloxanes and downstream silicone specialties, have multiple applications and are serving several end-markets. The division has a global production footprint with sites in France and China and provides both upstream and downstream specialty exposure.

The Silicones business reported a year-to-date operating income of 10,962 million Norwegian kroner (about €932 million), which was 2% higher than the corresponding period in 2023, Elkem said. The year-to-date EBITDA was 145 million Norwegian kroner (about €12.3 million) as of 30 September 2024.

According to Elkem, the improvements in 2024 results are driven by operational efficiencies, better utilization and higher volumes, as well as ramp-up of new capacity. The financial improvements in the Silicones division have continued throughout 2024, the company stated.

© noprati - stock.adobe.com
© noprati - stock.adobe.com

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.